ClinicalTrials.Veeva

Menu

Multicentre Observational Study on Management COVID 19 Positive Outpatients in a French Cluster. (COVID AMBU 60)

M

Maison de Sante Pluridisciplinaire de Creil

Status

Unknown

Conditions

Covid-19

Treatments

Other: observational

Study type

Observational

Funder types

Other

Identifiers

NCT04363099
2020-A01059-30

Details and patient eligibility

About

Since December 2019, a new agent, the coronavirus SARS-Cov-2, has spread from China to the rest of the world causing an international epidemic of respiratory diseases called COVID-19. Oise was one of the first clusters in France, with more than 4,000 confirmed cases. A significant proportion (80%) of patients with COVID-19 are ambulatory. However, few data are available for this particular population in France. Thus, few clear recommendations are available.

We propose to conduct a large cohort of observation of suspected or confirmed COVID-19 patients on an ambulatory basis in the Oise region. This observatory will make it possible to describe the epidemiological characteristics and initial management of COVID-19 patients and to identify early severity factors.

Enrollment

1,000 estimated patients

Sex

All

Ages

Under 99 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • patients with covid 19 symptoms
  • patients who had a contact with a person PCR Covid 19+

Exclusion criteria

  • none

Trial design

1,000 participants in 1 patient group

outpatients COVID 19 positive
Treatment:
Other: observational

Trial contacts and locations

1

Loading...

Central trial contact

Svetlane DIMI, M.D

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems